SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development

被引:95
作者
Zhu, PP
Soderblom, C
Tao-Cheng, JH
Stadler, J
Blackstone, C
机构
[1] NINDS, Cellular Neurol Unit, NIH, Bethesda, MD 20892 USA
[2] NINDS, Electron Microscopy Facil, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1093/hmg/ddl054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hereditary spastic paraplegias (HSPs) (SPG1-29) comprise a group of inherited neurological disorders characterized principally by spastic lower extremity weakness due to a length-dependent, retrograde axonopathy of corticospinal motor neurons. Mutations in the gene encoding the dynamin superfamily member atlastin-1, an oligomeric GTPase highly localized to the Golgi apparatus in the adult brain, are responsible for SPG3A, a common autosomal dominant HSP. A distinguishing feature of SPG3A is its frequent early onset, raising the possibility that developmental abnormalities may be involved in its pathogenesis. Here, we demonstrate that several missense SPG3A mutant atlastin-1 proteins have impaired GTPase activity and thus may act in a dominant-negative, loss-of-function manner by forming mixed oligomers with wild-type atlastin-1. Using confocal and electron microscopies, we have also found that atlastin-1 is highly enriched in vesicular structures within axonal growth cones and varicosities as well as at axonal branch points in cultured cerebral cortical neurons, prefiguring a functional role for atlastin-1 in axonal development. Indeed, knock-down of atlastin-1 expression in these neurons using small hairpin RNAs reduces the number of neuronal processes and impairs axon formation and elongation during development. Thus, the 'long axonopathy' in early-onset SPG3A may result from abnormal development of axons because of loss of atlastin-1 function.
引用
收藏
页码:1343 / 1353
页数:11
相关论文
共 44 条
[1]   Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A [J].
Abel, A ;
Fonknechten, N ;
Hofer, A ;
Dürr, A ;
Cruaud, C ;
Voit, T ;
Weissenbach, J ;
Brice, A ;
Klimpe, S ;
Auburger, G ;
Hazan, J .
NEUROGENETICS, 2004, 5 (04) :239-243
[2]  
Baas Peter W., 2001, Neuron, V32, P981, DOI 10.1016/S0896-6273(01)00556-6
[3]   Interaction of the deafness-dystonia protein DDP/TIMM8a with the signal transduction adaptor molecule STAM1 [J].
Blackstone, C ;
Roberts, RG ;
Seeburg, DP ;
Sheng, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (02) :345-352
[4]   Emerging functions of mammalian mitochondrial fusion and fission [J].
Chen, HC ;
Chan, DC .
HUMAN MOLECULAR GENETICS, 2005, 14 :R283-R289
[5]   Is the transportation highway the right road for hereditary spastic paraplegia? [J].
Crosby, AH ;
Proukakis, C .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (05) :1009-1016
[6]   Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation [J].
Dalpozzo, F ;
Rossetto, MG ;
Boaretto, F ;
Sartori, E ;
Mostacciuolo, ML ;
Daga, A ;
Bassi, MT ;
Martinuzzi, A .
NEUROLOGY, 2003, 61 (04) :580-581
[7]   OPA1 (Kjer type) dominant optic atrophy: A novel mitochondrial disease [J].
Delettre, C ;
Lenaers, G ;
Pelloquin, L ;
Belenguer, P ;
Hamel, CP .
MOLECULAR GENETICS AND METABOLISM, 2002, 75 (02) :97-107
[8]   Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia [J].
Dürr, A ;
Camuzat, AS ;
Colin, E ;
Tallaksen, C ;
Hannequin, D ;
Coutinho, P ;
Fontaine, B ;
Rossi, A ;
Gil, R ;
Rousselle, C ;
Ruberg, M ;
Stevanin, G ;
Brice, A .
ARCHIVES OF NEUROLOGY, 2004, 61 (12) :1867-1872
[9]   Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon [J].
Errico, A ;
Claudiani, P ;
D'Addio, M ;
Rugarli, EI .
HUMAN MOLECULAR GENETICS, 2004, 13 (18) :2121-2132
[10]   Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing [J].
Evans, KJ ;
Gomes, ER ;
Reisenweber, SM ;
Gundersen, GG ;
Lauring, BP .
JOURNAL OF CELL BIOLOGY, 2005, 168 (04) :599-606